Surgalign
About Surgalign
Surgalign Holdings, Inc. is a global medical technology company dedicated to advancing spine care through innovative solutions, including digital technologies, to improve patient outcomes. The company offers a comprehensive portfolio of spinal hardware implants for various procedures, such as fusion in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for sacroiliac joint fusion. They also provide a range of advanced and traditional orthobiologics (biomaterials).
A key focus for Surgalign is its HOLO AI platform, an artificial intelligence-driven, augmented reality (AR) guidance system for spine surgery. This platform utilizes AI to process intraoperative images, autonomously segmenting and labeling anatomy, and planning patient-specific pedicle screw trajectories that are then approved by the surgeon. The HOLO Portal system, part of this platform, uses AR to overlay the segmented AI reconstruction over the patient’s actual anatomy, providing real-time 3D visualization during surgical procedures to guide instruments and enhance precision. Surgalign aims to integrate this digital surgery platform to improve patient outcomes and drive the adoption of its spinal hardware implants and biomaterials products.
Focus Areas
Business Intelligence
| Key Investors | Water Street Healthcare Partners |
| Partnerships | PRIA Healthcare, Dr. Pierce Nunley (Spine Institute of Louisiana), Dr. Alexander Vaccaro |
| Acquisitions | Holo Surgical Inc. (acquired by Surgalign), Inteneural Networks (investment by Surgalign), Prompt Prototypes (acquired by Surgalign). Surgalign's Digital Health Assets were acquired by Augmedics, and its Hardware and Biologics Business was acquired by Xtant Medical Holdings. |
| Technology | HOLO AI digital health platform, HOLO Portal surgical guidance system (AI-driven augmented reality), TETRAfuse® 3-D |
| FDA Clearances | 2 (HOLO Portal surgical guidance system, Cortera spinal fixation system) cleared products (estimated) |
What Physicians Need to Know
For physicians, Surgalign's HOLO Portal system offers several advantages. It provides intelligent solutions designed to improve patient outcomes by delivering more accurate and efficient care in the surgical environment. The system's AI autonomously processes intraoperative images to create patient-specific plans and displays anatomy in 3D using AR, which can lead to less tissue damage due to improved visualization. Surgeons can leverage this technology to gain information they might currently be missing, enhancing surgical decisions and potentially reducing operative time. Additionally, HOLO AI Insights can assist in clinical research by transforming unstructured medical imaging data into structured datasets for new clinical insights.
Surgalign's HOLO AI digital health platform is designed with a vision for broader application across various healthcare specialties and throughout the care continuum. The HOLO AI Insights platform is integrated with the HOLO Portal spine system. While the company has faced bankruptcy proceedings and its digital health assets were acquired by Augmedics in 2023, the underlying technology and its potential for integration within augmented reality surgical navigation platforms remain significant.
What the Web Says
Surgalign, a medical technology company focused on spine care, has faced significant challenges, including filing for Chapter 11 bankruptcy in June 2023 and settling with the SEC for inflating reported revenue between 2015 and 2019. While some former employees praised the company culture and management, others cited a lack of fiscal controls and a decline in the work environment leading up to its bankruptcy. Surgalign developed products like the Coflex Interlaminar Stabilization device and the HOLO AI system for spine surgery.
Overall: NegativeStrengths
- Developed and distributed great products, such as the Coflex device and HOLO AI.
- Wonderful company culture and supportive colleagues (prior to bankruptcy).
- Excellent management and growth opportunities (prior to bankruptcy).
- Good benefits (prior to bankruptcy).
- HOLO AI technology has significant market opportunity in healthcare.
Limitations
- Company filed for Chapter 11 bankruptcy in June 2023.
- Lacked fiscal controls, leading to a flagship development project being a commercial failure.
- Inflated reported revenue by shipping products early without customer approval between 2015 and 2019.
- Settled with the U.S. Securities and Exchange Commission for $2 million due to past activities.
- Work environment declined and company shut down due to running out of money.
- Received notice of non-compliance with minimum stockholders' equity requirement in April 2023.
Based on reviews from: Indeed.com, Reddit, symplr, Becker's Spine Review, YouTube, SEC Filing (Form 8-K), IndexBox
Last updated: 2026-06-19
Videos
News, demos, and interviews about Surgalign.
Videos load interactively. If none appear, search YouTube for Surgalign →
Press & Coverage
Frequently Asked Questions
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]